Literature DB >> 23975921

Unusual cause of cholestatic jaundice in a patient with AIDS.

Su Bin Kim1, Makardhwaj Sarvadaman Shrivastava, Jesus M Anampa, Marianna Strakhan.   

Abstract

A 61-year-old man with AIDS on chronic highly active antiretroviral treatment (HAART) presented with lethargy and jaundice and was found to have abnormal liver function tests (LFTs). Investigations including viral/autoimmune markers and imaging were unrevealing, except for positive Epstein-Barr virus. HAART was held, however, transaminases and total bilirubin continued to rise. The liver biopsy revealed classical Hodgkin's lymphoma (HL). HL presenting only with liver findings without lymphadenopathy is rare. Extreme cases can lead to fulminant liver failure. The bone marrow biopsy and dramatic elevation in serum ferritin were consistent with haemophagocytic lymphohistiocytosis. Finding a chemotherapy regimen was challenging given abnormal LFTs and HAART interactions. Initial chemotherapy regimen has successfully decreased LFTs; however, it was limited by pancytopenia. The patient's regimen was changed, however second regimen was complicated by neuropathy. LFTs improved and the patient was able to receive the standard care chemotherapy for HL with significant clinical, laboratory and radiological improvement.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975921      PMCID: PMC3762416          DOI: 10.1136/bcr-2013-200113

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

Review 1.  Haemophagocytic syndrome and HIV.

Authors:  Tomas Doyle; Sanjay Bhagani; Kate Cwynarski
Journal:  Curr Opin Infect Dis       Date:  2009-02       Impact factor: 4.915

2.  Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.

Authors:  F Cervantes; J Briones; M Bruguera; C Font; J M Grau; C Rozman; E Montserrat
Journal:  Ann Hematol       Date:  1996-06       Impact factor: 3.673

3.  Cancer burden in the HIV-infected population in the United States.

Authors:  Meredith S Shiels; Ruth M Pfeiffer; Mitchell H Gail; H Irene Hall; Jianmin Li; Anil K Chaturvedi; Kishor Bhatia; Thomas S Uldrick; Robert Yarchoan; James J Goedert; Eric A Engels
Journal:  J Natl Cancer Inst       Date:  2011-04-11       Impact factor: 13.506

Review 4.  Liver disease in the HIV-infected individual.

Authors:  Jennifer C Price; Chloe L Thio
Journal:  Clin Gastroenterol Hepatol       Date:  2010-09-17       Impact factor: 11.382

5.  [Hodgkin lymphoma with hepatic involvement treated with dexametasone, gemcitabine and cisplatin as a bridge to standard therapy: report of one case].

Authors:  Matías Orellana; Valeria Buttinghausen; Augusto Aspillaga M; Mauricio Chandía C
Journal:  Rev Med Chil       Date:  2012-07       Impact factor: 0.553

6.  Successful use of full-dose dexamethasone, high-dose cytarabine, and cisplatin as part of initial therapy in non-hodgkin and hodgkin lymphoma with severe hepatic dysfunction.

Authors:  Jeanne McCarthy; Ajay K Gopal
Journal:  Clin Lymphoma Myeloma       Date:  2009-04

7.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 8.  Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: statistical analysis of all published cases and literature review.

Authors:  Ari Ballonoff; Brian Kavanagh; Russell Nash; Harry Drabkin; James Trotter; Luciano Costa; Rachel Rabinovitch
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

9.  Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

Authors:  Thomas Powles; David Robinson; Justin Stebbing; Jonathan Shamash; Mark Nelson; Brian Gazzard; Sundhiya Mandelia; Henrik Møller; Mark Bower
Journal:  J Clin Oncol       Date:  2008-12-29       Impact factor: 44.544

10.  HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART.

Authors:  Caron A Jacobson; Jeremy S Abramson
Journal:  Adv Hematol       Date:  2012-01-05
  10 in total
  1 in total

Review 1.  Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.

Authors:  Steve Hu; Pranshu Bansal; David Lynch; Cristhiam Mauricio Rojas Hernandez; Zoneddy Dayao
Journal:  J Med Case Rep       Date:  2016-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.